Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma
- 31 March 1993
- Vol. 5 (2) , 133-143
- https://doi.org/10.1016/1043-4666(93)90052-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.The Journal of Experimental Medicine, 1992
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Multiple cytokine interactions regulate Ly-6E antigen expression: Cooperative Ly-6E induction by IFNs, TNF, and IL-1 in a T cell lymphoma and in its induction-deficient variantsCellular Immunology, 1991
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Chemistry and Biology of the Immunophilins and Their Immunosuppressive LigandsScience, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Kinetic analysis of Ly‐6 gene induction in a T lymphoma by interferons and interleukin 1, and demonstration of Ly‐6 inducibility in diverse cell typesEuropean Journal of Immunology, 1989
- Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol esterNature, 1985
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975